Artiva Biotherapeutics Announces First Patient Dosed in Phase 1 Trial of AlloNK® Cell Therapy Candidate in Lupus Nephritis

News
2024
2023
Archive
Search news articles

December 2, 2022

Lilly Completes Acquisition of Akouos Expanding Efforts to Help People with Genetic Diseases
December 1, 2022

Womens Health Advocate Amy Schumer Joins TMRW Life Sciences as Investor
December 1, 2022

Cidara Therapeutics Announces Issuance of First U.S. Patent for CD388
December 1, 2022

AbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases
November 30, 2022

Dianthus Therapeutics Announces First Participant Dosed in Phase 1 Trial of DNTH103, a Selective Inhibitor of the Classical Complement Pathway
November 30, 2022

Lilly and Akouos Announce Expiration of Akouos Tender Offer
November 29, 2022

Bionano Genomics to Acquire Purigen Biosystems to Enable Further Simplified and Accelerated DNA Isolation for Optical Genome Mapping (OGM) and Address Difficult Sample Types in New Applications with Isotachophoresis (ITP) on the Ionic Purification System
November 28, 2022

CinCor Pharma Announces Topline Data for Phase 2 HALO Trial Evaluating Selective Aldosterone Synthase Inhibitor Baxdrostat in Uncontrolled Hypertension
November 28, 2022

Cidara Therapeutics and Melinta Therapeutics Announce Publication of Data From the Global Phase 3 Pivotal Restore Trial of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis in the Lancet
November 28, 2022

IDEAYA Biosciences Appoints Darrin M. Beaupre, M.D., Ph.D., as Chief Medical Officer to Lead Clinical Development of Expanding Clinical Pipeline